GILD - Gilead Sciences COM
This page shows which of the focused investors we track hold GILD and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2012 it was held by 5 managers with an aggregate reported value of $141.26M, which is 0.02% of the combined portfolio.
As of Q3 2012, 5 tracked institutional managers held GILD (Gilead Sciences COM) with an aggregate reported value of $141.26M — 0.02% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades GILD — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2012
- Ticker
- GILD
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Rolfe - Wedgewood Partners | 4.95% | Reduce -29.5% | 899,059 | $59.64M |
| 2 | Howard Marks - Oaktree Capital Management | 0.86% | Reduce -67.3% | 32,025,000 | $50.28M |
| 3 | Stanley Druckenmiller - Duquesne Family Office LLC | 1.54% | Reduce -10.8% | 422,000 | $27.99M |
| 4 | Torray Funds - Torray Funds | 0.74% | Reduce -9.8% | 50,441 | $3.35M |
| 5 | First Eagle - First Eagle Investment Management | 0.00% | - | 200 | $13K |
Loading holder history for GILD…